MCL1 and B-cell chronic lymphocytic leukemia: For instance, MI-2 significantly decreased anti-apoptotic proteins such as BCL2 and MCL-1 (myeloid leukemia 1) and activated the intrinsic apoptosis pathway in chronic lymphocytic leukemia [41].